CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/2-Figure1-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Detection of the CA19-9 antigen on individual protein carriers | Download Scientific Diagram
CA 19-9 Antigen - an overview | ScienceDirect Topics
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter - ScienceDirect
Epredia™ Lab Vision™ CA19-9/Sialyl Lewis<sup> a</sup> (GI Tumor Marker) Ab-3, Mouse Monoclonal Antibody 1mL; Unlabeled; Supernatant Epredia™ Lab Vision™ CA19-9/Sialyl Lewis<sup> a</sup> (GI Tumor Marker) Ab-3, Mouse Monoclonal Antibody | Fisher Scientific
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies | bioRxiv
Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
Multivariate Analysis: Lewis Antigen Negative v CA 19-9 180 v CA 19-9 180 | Download Table
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter - ScienceDirect
Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
IVD Antibody Development Services for CA19-9 Marker - Creative Biolabs
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
CA19-9 - Wikipedia
Electrochemical immunoplatform to help managing pancreatic cancer - ScienceDirect
Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
Cancers | Free Full-Text | Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels
CA 19-9 Tumor Marker Blood Test | Carbohydrate Antigen 19-9 | CA 19-9 | Pancreatic Cancer Screening - YouTube
